Atrial fibrillation (AF) is associated with abnormal sarcoplasmic reticulum (SR) calcium release, which is promoted by adenosine A 2A receptor (A 2A R) activation. Here, we tested the hypothesis that abnormal calcium release in AF is linked to A 2A R remodelling.
Introduction
Experimental studies in human atrial tissue have disclosed an association between atrial fibrillation (AF) and abnormalities in intracellular calcium handling. 1 -3 Indeed, human atrial myocytes (HAMs) from patients with AF exhibit a reduced L-type calcium current (I Ca ) density 1 and increased spontaneous sarcoplasmic reticulum (SR) calcium release. 3 The latter activates Ca 2+ extrusion from the cell by the Na-Ca exchanger (NCX), generating an inward NCX current (I NCX ) and a concurrent membrane depolarization. Such abnormal depolarizations (afterdepolarizations) are known to favour the occurrence of arrhythmias by triggered † Authors contributed equally. ‡ Joint senior authors. activity 4 and to promote reinitiation of AF in isolated atrial preparations. 5 The mechanism underlying abnormal SR calcium release in AF is not well known but appears to be linked to an increased ryanodine receptor (RyR2) phosphorylation. 2 Since protein kinase A can mediate RyR2 phosphorylation, 4,6 -8 it is conceivable that membrane receptors coupled to adenylate cyclase through G s -proteins modulate intracellular calcium handling. Indeed, A 2A Rs are expressed in human right atrium and modulate the frequency of spontaneous calcium release. 9 Thus, adenosine-mediated signalling pathways could, in spite of adenosine's ability to block supraventricular arrhythmias by slowing the AV-nodal conduction, 10 contribute to the initiation of AF and this might explain why administration of an adenosine bolus can induce transient atrial arrhythmia 11 Also, abnormal adenosine levels have been reported during ischaemia and associated to the initiation of AF. 12 In spite of this, investigation has so far focused on remodelling of other cell membrane receptors in patients with AF 13 -16 and it remains to be determined whether AF is associated to remodelling of A 2A Rs and if such remodelling has any functional consequences. This study aimed to test the hypothesis that the abnormal SR calcium release seen in patients with AF is linked to remodelling of atrial A 2A Rs.
Methods

Human samples
Human atrial myocytes were isolated by enzymatic digestion of human right atrial tissue samples as previously described. 3 A total of 254 myocytes from 82 patients undergoing cardiac surgery were used for electrophysiological experiments. To optimize sample quality, samples were stored in cold, oxygenated Tyrode solution immediately upon excision and myocyte isolation was begun within 5 min after excision. Thirty-one patients had AF while the remaining patients had no history of AF. Of these, 42 had normal left atrial size (,41 mm) and 9 had atrial dilation (AD). The number of patients used in specific experiments is indicated where appropriate. Patients treated with Ca
2+
antagonists were excluded from the study. Additional clinical information is given in Table 1 . Permission to use atrial samples was obtained from each patient. The study was conducted in accordance with the Declaration of Helsinki principles, and approved by the Ethical Committee of our institution.
Gel electrophoresis, immunoblotting, and quantitative real-time PCR
Membranes from right atrial tissue or HEK cells were prepared as previously described 17 ). Phosphorylation of the RyR2 at ser-2808 was detected using anti-RyR2 (1:2000, Calbiochem) and anti-phospho RyR2 (1:5000, ser-2808, Badrilla).
Total RNA was isolated from human right atrial samples using a commercially available kit. First-strand cDNA was synthesized from 1 mg of total RNA using random hexamer primer and SuperScript II Rnase H 2 Reverse Transcriptase (Gibco BRL, Gaithersburg, MD, USA 
Measurements of spontaneous calcium release and ionic currents in isolated myocytes
Calcium sparks and calcium waves were detected in fluo-4 loaded HAMs at room temperature, using the line scanning mode (Figure 2) or the frame scanning mode ( Figure 7 ) of a Leica TCS SP5 AOBS laser scanning confocal microscope. Fluo-4 was excited at 488 nm and fluorescence emission was detected between 500 and 650 nm at scan rates of 1 kHz for line scanning or 100 Hz for frame scanning (each frame was 512 × 140 pixels). Spark detection and ionic current recordings (using a HEKA EPC-10 amplifier) were done as previously described. 3, 9 Briefly, spontaneous I NCX , activated by spontaneous calcium waves, 3, 9 were recorded at 280 mV. The caffeine releasable calcium load was obtained by integration of the I NCX elicited by rapid exposure to 10 mM caffeine at rest. 3, 9 The ability of the SR to reload calcium was also assessed with a protocol consisting in two caffeine pulses applied immediately before and after a train of 30 stimulation pulses. The first caffeine pulse served to clear the SR calcium content and the second pulse to measure re-loading after the 30 stimulation pulses (used for Figure 3B ). The current-voltage relationship for I Ca was obtained using test potentials between 240 and +50 mV. Steady-state effects on I Ca were evaluated using repetitive depolarization to 0 mV for 200 ms at 0.5 Hz. The amphotericin perforated-patch configuration was used in all experiments except for Figure 7 where the ruptured patch configuration was used. Recording solutions and criteria for acceptable access resistance have previously been described. 3, 9 No series resistance compensation was employed.
Data analysis and statistics
Experiments were carried out without knowledge about the clinical data of the patients. Unless otherwise stated, average values from Adenosine A 2A receptors in atrial fibrillation each patient were used for statistical analysis and expressed as mean + standard deviation. Data sets were tested for normality. A two-sided Student's t-test was used to assess significant differences when testing a specific effect. ANOVA was used for comparison of multiple effects and Student -Newman -Keuls post-test was used to evaluate the significance of specific effects. A x 2 test was used to evaluate diagnosis and pharmacological treatments in Table 1 . The statistical analysis was done with SPSS Statistics 17.0 and Sigma Stat 3.1 packages. Differences were considered statistically significant for P , 0.05.
Results
Increased A 2A R expression in patients with atrial fibrillation Figure 1A and B shows that both monomeric and dimeric A 2A R species are present in human right atrium. The dimeric A 2A R species, which is the functional form located on the cell surface, 17 was sparse in samples from patients without AF and no AD, while dimeric A 2A R expression was moderately higher in patients without AF but with AD, and markedly higher in patients with AF ( Figure 1B ). Figure 1C shows that also A 2A R mRNA, measured by quantitative real-time PCR, increased in patients with AD and with AF.
Effects of A 2A R activation on spontaneous sarcoplasmic reticulum calcium release
To assess the potential functional effects of A 2A R remodelling, we first analysed the effect of A 2A R stimulation on spontaneous SR calcium release (calcium sparks and calcium waves) in isolated HAMs from six patients with and eight patients without AF. Preincubation with the A 2A R agonist CGS21680, markedly increased both the calcium spark and calcium wave frequency in patients with AF ( Figure 2) . Since the increase in spontaneous SR calcium release may result from a direct effect on the RyR2 or from an effect on the SR calcium content 18 we also analysed the effect of CGS21680 on the amplitude and decay of 142 calcium sparks from six patients with AF. Neither the amplitude (1.62 + 0.12 vs 1.59 + 0.10, P ¼ 0.74) nor the time constant for the decay of the calcium sparks (45 + 7 vs 52 + 15 ms, P ¼ 0.14) was altered by CGS21680.
To determine whether the increased spontaneous SR calcium release was secondary to an action on the membrane potential, perforated patch-clamp technique was used to clamp the membrane potential. This did not impede that CGS21680 increased the number of I NCX activated by spontaneous SR calcium release in patients with AF ( Figure 3A) . Moreover, CGS21680 induced a modest but significant increase in the spontaneous I NCX frequency in myocytes from patients with AD but no AF. Theoretically, A 2A R 
A 2A R activation increases RyR2 phosphorylation in fibrillating atria
To test whether A 2A R-activation affects the phosphorylation state of the RyR2, we used a phospho-specific antibody recognizing the RyR2 when phosphorylated at the residue ser-2808. Figure 4 shows that the ratio of ser-2808 phosphorylated RyR2:total RyR2 was significantly higher in atrial tissue samples from patients with AF than from patients without AF. Moreover, A 2A R stimulation with CGS21680 increased RyR2 phosphorylation at ser-2808 in AF patients but not in patients without AF. The effect of isoproterenol served as a positive control for phosphorylation of RyR2 at ser-2808. 2 Interestingly, the spontaneous I NCX frequency ( Figure 3A) was proportional to the ratio S2808:RyR2 total (Figure 4) , being lowest in samples from patients without AF (no AF) incubated with vehicle and highest in samples from patients with AF incubated with CGS21680.
Effects on sarcoplasmic reticulum calcium handling of A 2A R blockade To test if the higher incidence of spontaneous calcium release observed in HAMs from AF patients is linked to increased A 2A R expression, the effects of A 2A R antagonists on SR calcium handling were compared in patients with and without AF. Figure 5A and B shows that A 2A R antagonism with ZM241385 reversibly reduced the spontaneous I NCX frequency in AF myocytes to levels observed in myocytes without AF. In contrast, ZM241385 did Figure 5C and D) or the caffeine-induced I NCX (97 + 36% of control in AF, P ¼ 0.77 and 101 + 15% of control in no AF, P ¼ 0.98).
Endogenous adenosine modulate sarcoplasmic reticulum calcium handling through A 2A R activation
The inhibition of spontaneous SR calcium release by A 2A R antagonists suggests that endogenously produced adenosine activate the A 2A Rs. In agreement with this, exogenous adenosine deaminase (ADA), which degrades the nucleoside, significantly reduced the spontaneous I NCX frequency, and the non-degradable A 2A R agonist CGS21680 reversed this effect ( Figure 6 ). Adenosine deaminase had no significant effect on caffeine-induced I NCX (93 + 18% of control in AF, P ¼ 0.34 and 109 + 24% of control in no AF, P ¼ 0.41).
To verify that endogenous adenosine can stimulate spontaneous calcium release, a subset of myocytes were infused with adenosine through the patch pipette. To track adenosine, 50 mM fluo-4 was included in the pipette solution and the concurrent rise in fluo-4 fluorescence was recorded using confocal calcium imaging ( Figure 7A ). The time-dependent increase in base-line fluorescence is shown in Figure 7B . Fitting of eight experiments with adenosine infusion gave a plateau of 0.85 + 0.40 and a time to half-maximum of 15 + 5 min. The increase in the cytosolic adenosine level can be calibrated (right-hand scale in Figure 7B ) if it is assumed to be proportional to the increase in the baseline fluorescence.
As shown in Figure 7C , adenosine infusion initially induced numerous calcium sparks and mini-waves that were gradually replaced by large calcium waves, and the effect of adenosine infusion on the wave frequency is summarized in Figure 7D . Using the calibrated adenosine signal, and fitting this data with a hyperbolic equation (Figure 7D inset) , the endogenous adenosine level is estimated to be 0.54 mM (x-offset), and the adenosine concentration for a half-maximal effect is estimated at 4.2 mM. Treatments with adenosine-containing (n ¼ 8) and adenosine-free solutions (n ¼ 8) had opposite and significantly different effects (P , 0.05, one-way ANOVA) on the frequency of calcium waves. In separate experiments, 150 nM extracellular ZM241385 inhibited the effect of internal perfusion with 30 mM adenosine ( Figure 7E) , confirming that adenosine is activating the A 2A R. at ser-2808. Western blot analysis performed with antibodies for total RyR2 (RyR total) and RyR2 phosphorylation at ser-2808 (S2808) in atrial tissue from patients without (no atrial fibrillation) and with atrial fibrillation. Samples were preincubated in oxygenated Tyrode solution for 20 min in control conditions (CON), with 200 nM CGS21680 (CGS), or with 1 mM isoproteronol (ISO). Densitometric analysis of RyR2 phosphorylation at ser2808 relative to total RyR2 is shown. Values for all treatments were significantly higher in atrial fibrillation than the corresponding value in no atrial fibrillation (P , 0.05, n ¼ 9). A significant difference (P , 0.05) from the corresponding control value is indicated with an asterisk above bars. 
Discussion
Remodelling of atrial adenosine A 2A receptors in atrial fibrillation
In this study, we report a 1.7-fold higher level of A 2A R mRNA in patients with AD and a four-fold increase in A 2A R mRNA levels in AF patients, which coincided with corresponding increases in the expression of both the monomeric and the homodimeric form of the A 2A R. The latter form is predominant at the cell surface, 19 mediating the signal transduction. Moreover, the overlapping distribution of A 2A Rs and RyR2s in HAMs 9 likely facilitates A 2A R-mediated stimulation of spontaneous SR calcium release. These findings suggest that AD and particularly AF have the potential to induce remodelling of A 2A Rs. The mechanism underlying the observed upregulation of A 2A Rs is unknown, but AF has been associated with energetic deficits, 20 which could modulate adenosine receptor expression. Moreover, the structural protein a-actinin located at the z-lines is known to interact with the A 2A R and modify its expression at the cell membrane, 17 and the AD present in the AD patients and AF patients could impose a mechanical stress on a-actinin and in turn modify A 2A R expression.
In line with the observed remodelling of A 2A Rs in AF, changes in the expression of other membrane receptors have also been reported in patients with AF; including angiotesin receptors, 13, 14 inositol 1,4,5-triphosphate (IP3) receptors, 16 opioid receptors, 15 and 5-HT 4 receptors. 21, 22 The concurrent remodelling of the different receptors may give rise to variable or even opposite effects on intracellular calcium handling. Indeed, upregulation of angiotensin, 5-HT 4 and IP3 receptors in AF is expected to promote intracellular calcium mobilization, 16, 22, 23 whereas downregulation of 5-HT 4 receptors is expected to reduce I Ca amplitude and SR calcium loading.
21,24
Remodelling of adenosine A 2A receptors linked to abnormal calcium handling Abnormal SR calcium release, a condition that favours the occurrence of arrhythmogenic afterdepolarizations, has previously been recognized in isolated right atrial myocytes from patients with AF 3 and attributed to an increased RyR2 activity. 2, 3 The specific mechanism underlying the association between AF and abnormal cellular calcium handling has not yet been elucidated, but the present data provide evidence for a functional link to atrial A 2A R remodelling. Thus, the natural ligand, adenosine, and selective A 2A R agonism increased spontaneous calcium release moderately in patients with AD and strongly in AF patients while selective A 2A R antagonism had the opposite effect in AF patients. There are several ways by which A 2A R stimulation could promote spontaneous calcium release from the SR: (i) by directly affecting the RyR2 activity, 4, 7 (ii) by increasing the SR calcium content, 25 or (iii) by promoting cross-talk between IP3 receptors and RyRs. 26 Our data indicate that the most likely mechanism for the increased SR calcium release in AF is an increased RyR2 phosphorylation. Thus, the ratio of phosphorylated RyR2 at ser-2808:total RyR2 was higher in AF patients than in patients without this arrhythmia, and A 2A R stimulation significantly increased RyR2 phosphorylation at ser-2808 in patients with AF.
In contrast, our findings do not support a substantial A 2A Rmediated modulation of the I Ca amplitude, the amplitude or decay of calcium sparks, the amplitude of spontaneous I NCX , or the SR calcium content. These findings indicate that A 2A R activation does not modify calcium extrusion on each spontaneous I NCX , and A 2A R activation is therefore unlikely to increase calcium entry between two successive I NCX . Furthermore, CGS21680 had a comparable effect in clamped ( Figure 3A ) and unclamped cells ( Figure 2C) , ensuring that the effect was not secondary to an effect on the resting membrane potential, which is known to modulate spontaneous SR calcium release. 27 In agreement with these findings, A 2A R stimulation increased cyclic AMP content but not phospholamban phosphorylation in guinea pig ventricle. 28 
Limitations of the model
A concern when interpreting data from human cardiomyocyte models is that clinical or therapeutical heterogeneity among patients with and without AF can potentially bias the results. To minimize this, patients treated with calcium antagonists were excluded from this study. Also, there is little evidence in the literature that the treatments that differed among patients with and without AF (statins, diuretics, acetyl salicylic acid, or dicoumarin, see Table 1 ) alter calcium handling in isolated cardiomyocytes. Moreover, unpublished observations from our laboratory show that these treatments do not affect I Ca , the caffeine releasable calcium load, or the spontaneous I NCX frequency in HAMs. Moreover, the observed remodelling of intracellular calcium handling is consistent with previous reports on human AF. 1, 3 The stimulatory effect of CGS21680 on spontaneous I NCX observed in the patients without AF (1-1.7 min 21 for patients without AD and 1.5 -3.3 min 21 for patients with AD) is also comparable with that of our previous study (1.2 -2.5 min 21 ). 9 Another potential concern is the specificity of the A 2A R agonists and antagonists. However, the A 2A R antagonists used are highly selective. 29 Finally, differences are known to exist between left and right atrial physiology, and we cannot infer that identical results will be obtained in the left atria.
Clinical implications
The arrhythmogenic potential of spontaneous calcium release in HAMs is based on reports showing involvement of the SR in the induction of afterdepolarizations and reinitiation of AF. 5 Likewise, spontaneous SR calcium release favours abnormal automaticity, 30 another mechanism contributing to atrial arrhythmias in humans. 31 Thus, abnormal SR calcium release may contribute to the initiation or recurrence of AF, and our study suggests that increased A 2A R expression in AF patients is a novel mechanism that may promote domestication of the arrhythmia by increasing spontaneous calcium release at baseline. Moreover, local atrial ischaemia can contribute to the development of AF 32 and a dramatic increase in interstitial adenosine levels has been observed during myocardial ischaemia. 33 In fact, our estimates of the (adenosine) at baseline (0.54 mM) and at half-maximal activation of calcium waves (4.2 mM) are well within the levels reported before and during ischaemia 33 and 4.2 mM is below levels reached when an adenosine bolus is used in clinical practice to induce ectopic atrial activity, 11 suggesting that periods of deficient circulation in atrial appendices of AF patients 34 has the potential to perpetuate AF through A 2A R-mediated stimulation of spontaneous SR calcium release. Adenosine is also known to inhibit AV-nodal conduction 10 and shorten the atrial refractory period. 35 The latter favours electrical re-entry and has been attributed to adenosine A 1 receptor activation and proposed to account for adenosine's proarrhythmic effect. 36 Theoretically, activation of adenosine A 3 receptors could produce a similar effect, but this receptor is not expressed in murine atria. 37 The A 2A R-mediated effects reported here are expected to have little effect on the refractory period, and likely represent a novel mechanism of particular relevance to the induction of ectopic activity and the (re)-initiation of AF. Moreover, the moderate remodelling of A 2A R signalling observed in patients without AF but with AD is in line with a moderate electrical remodelling reported in a sheep model of AD 38 and in patients with high risk of AF, suggesting that A 2A R-linked changes in calcium handling precedes AF. Prevention of AF recurrences by A 2A R antagonism has not yet been assessed but the ability of A 2A R antagonist to inhibit spontaneous SR calcium release without compromising I Ca or the SR calcium content affords a pathophysiological rationale for such an approach to be attempted.
In summary, this is to the best of our knowledge, the first study to demonstrate a functional link between high baseline levels of spontaneous calcium release in patients with AF and increased A 2A R expression, and RyR phosphorylation. These findings propose abnormal A 2A R activation in AF as a novel mechanism contributing to the domestication of AF. Moreover, the selective reduction in spontaneous calcium release by A 2A R antagonists observed in myocytes from patients with AF affords a pathophysiological rationale for testing A 2A R blockade as a new therapeutical approach to prevent recurrence of AF.
